[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C50H64N4O13 — CID 135573611

IUPAC[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCOc1cccc(CN2CCN(/N=C\c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(O/C=C/C(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)/C=C/C=C(\C)C(=O)N4)O6)CC2)c1
InChIInChI=1S/C50H64N4O13/c1-26-13-11-14-27(2)49(62)52-40-35(24-51-54-20-18-53(19-21-54)25-33-15-12-16-34(23-33)63-9)44(59)37-38(45(40)60)43(58)31(6)47-39(37)48(61)50(8,67-47)65-22-17-36(64-10)28(3)46(66-32(7)55)30(5)42(57)29(4)41(26)56/h11-17,22-24,26,28-30,36,41-42,46,56-60H,18-21,25H2,1-10H3,(H,52,62)/b13-11+,22-17+,27-14+,51-24-
InChIKeyQNSNDBQQLXTTTN-IYQJLCCKSA-N
MW929.08 g/mol
LogP5.91
Rot. Bonds7

About [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (PubChem CID 135573611) has the molecular formula C50H64N4O13 and a molecular weight of 929.08 g/mol. Its IUPAC name is [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.

Molecular Properties

Compound Name[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
PubChem CID135573611
Molecular FormulaC50H64N4O13
Molecular Weight929.08 g/mol
Exact Mass928.45
IUPAC Name[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCOc1cccc(CN2CCN(/N=C\c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(O/C=C/C(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)/C=C/C=C(\C)C(=O)N4)O6)CC2)c1
InChIInChI=1S/C50H64N4O13/c1-26-13-11-14-27(2)49(62)52-40-35(24-51-54-20-18-53(19-21-54)25-33-15-12-16-34(23-33)63-9)44(59)37-38(45(40)60)43(58)31(6)47-39(37)48(61)50(8,67-47)65-22-17-36(64-10)28(3)46(66-32(7)55)30(5)42(57)29(4)41(26)56/h11-17,22-24,26,28-30,36,41-42,46,56-60H,18-21,25H2,1-10H3,(H,52,62)/b13-11+,22-17+,27-14+,51-24-
InChIKeyQNSNDBQQLXTTTN-IYQJLCCKSA-N
XLogP5.91
TPSA229.38 Ų
H-Bond Donors6
H-Bond Acceptors16
Rotatable Bonds7
Heavy Atoms67
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500929.08
LogP ≤ 55.91
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hzone_phenol_A(479)', 'substructure': 'N/A'}, {'alert_name': 'hzone_pipzn(79)', 'substructure': 'N/A'}, {'alert_name': 'keto_naphthol_A(2)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}

Analyze [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The IUPAC name of [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (CID 135573611) is [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
What is the SMILES notation for [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The canonical SMILES for [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is COc1cccc(CN2CCN(/N=C\c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(O/C=C/C(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)/C=C/C=C(\C)C(=O)N4)O6)CC2)c1.
What is the InChIKey of [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The InChIKey is QNSNDBQQLXTTTN-IYQJLCCKSA-N. The full InChI is InChI=1S/C50H64N4O13/c1-26-13-11-14-27(2)49(62)52-40-35(24-51-54-20-18-53(19-21-54)25-33-15-12-16-34(23-33)63-9)44(59)37-38(45(40)60)43(58)31(6)47-39(37)48(61)50(8,67-47)65-22-17-36(64-10)28(3)46(66-32(7)55)30(5)42(57)29(4)41(26)56/h11-17,22-24,26,28-30,36,41-42,46,56-60H,18-21,25H2,1-10H3,(H,52,62)/b13-11+,22-17+,27-14+,51-24-.
What are the key properties of [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate has a molecular weight of 929.08 g/mol, XLogP of 5.91, 7 rotatable bonds, 6 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-26-[(Z)-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is sourced from PubChem (CID 135573611), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).